Identification and validation of differentially expressed genes in allergic asthma pathogenesis using whole-transcriptome sequencing.

Objective: This study aims to systematically identify differential gene expression profiles in patients with allergic asthma through whole-transcriptome sequencing and validate the role of these genes in asthma pathogenesis, thereby uncovering potential molecular mechanisms. Methods: This study recruited a cohort of 80 individuals diagnosed with allergic asthma and 40 healthy controls. RNA was extracted from both peripheral blood and airway samples, and sequencing was performed using the Illumina NovaSeq 6000 platform. Potential differential genes were confirmed through three independent techniques to validate the findings: quantitative reverse transcription polymerase chain reaction (qRT-PCR), immunohistochemistry, and Western blot analysis. Differential gene expression was analyzed using DESeq2 software, providing a rigorous statistical framework for RNA-Seq data interpretation. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were employed to elucidate the biological significance of the differentially expressed genes, offering insights into the molecular mechanisms underlying allergic asthma. Results: Differential expression analysis identified multiple genes with significant differences between the patient and control groups. Inflammatory-related genes such as Conclusion: Differential gene expression profiles play a crucial role in the pathogenesis of asthma. This study provides important evidence for understanding the molecular mechanisms of asthma and developing novel targeted therapeutic strategies.